All In MedTech

FDA Clearance Tracker · P960009-S422

Activa® Deep Brain Stimulation Therapy System, Percept™ PC BrainSense™

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 25, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 25, 2022

Approved

Time to decision

29 days

Received Feb 24, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P960009-S422
Device name
Activa® Deep Brain Stimulation Therapy System, Percept™ PC BrainSense™
Applicant location
Minneapolis, MN
Received
Feb 24, 2022
Decided
Mar 25, 2022
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P960009

Device type

Device class
Class III

Every decision under product code MHY

FDA's approval statement

As written in FDA's record.

Approval of the following revisions to the protocol for the post-approval study (PAS), DBS for Epilepsy New Enrollment PAS: a) evaluate seizure worsening and changes in seizure frequency over time without formal hypothesis testing for safety; b) change the sample size for the primary effectiveness objective to approximately 72 evaluable subjects at 3 years (140 enrolled subjects to have 90 implanted subjects) from 112 evaluable subjects at 3 years (216 enrolled subjects to have 140 implanted subjects); c) change in baseline diary length from 84 days to 28 days; d) update to estimated study milestones; e) migration to a new Medtronic Clinical Investigation Plan (CIP) template; and f) general clerical edits (e.g., addition of lead Principal Investigator name and contact information, formatting, grammar/wording for consistency, improved readability, etc.).

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.